Non-Resolving Pneumonia — Comprehensive MD Exam Answer (15 Marks)

Definition

• Lack of clinical improvement or worsening of symptoms despite a minimum of 10 days of appropriate antibiotic therapy, OR
• Failure of radiographic abnormalities to resolve after 2–3 months of treatment.

Normal radiographic resolution of pneumonia varies: 1–2 weeks for mild cases, up to 2 months for severe or complicated cases — influenced by the causative organism, patient age, and comorbidities.

Causes / Etiology

A. Infectious Causes

B. Non-Infectious / Mimics of Pneumonia

C. Host Factors (Impaired Defense Mechanisms)

• Immunosuppression: HIV/AIDS (CD4 < 200 → PCP), malignancy, transplant, steroids
• Structural lung disease: COPD, bronchiectasis, cystic fibrosis
• Diabetes mellitus: impaired neutrophil function
• Alcoholism: aspiration risk + impaired immunity
• Endobronchial obstruction: foreign body, tumor causing post-obstructive pneumonia
• Empyema or parapneumonic effusion: undrained collection preventing resolution

Mnemonic: CRITICS (Non-resolving causes)

Clinical Assessment

History

• Duration and progression of symptoms
• Antibiotic type, dose, duration, compliance
• Travel history (endemic fungi, TB exposure)
• Occupational / drug exposure
• Smoking history (risk of carcinoma)
• Immunosuppression (HIV, transplant, steroids, diabetes)
• Recurrence pattern (same segment → obstruction; different segments → systemic cause)

Examination

• Signs of consolidation (dullness, bronchial breathing, crepitations)
• Lymphadenopathy (malignancy, lymphoma, sarcoid)
• Clubbing (carcinoma, bronchiectasis)
• Weight loss / cachexia
• Extrapulmonary signs (skin nodules → sarcoid/fungal; joint swelling → vasculitis)

Investigations

Baseline

• CXR — extent, cavitation, effusion, hilar adenopathy; compare with prior films
• CBC — leukocytosis (infection), eosinophilia (eosinophilic pneumonia), lymphopenia (HIV)
• CRP / ESR / Procalcitonin — inflammatory markers
• Blood cultures (if not done or repeated)
• Sputum — Gram stain, culture & sensitivity, AFB smear/culture, cytology
• Blood glucose / HbA1c — exclude undiagnosed diabetes

Targeted Microbiology

• Urinary antigen for Legionella and S. pneumoniae
• HIV serology
• Fungal serology (Aspergillus galactomannan, beta-D-glucan)
• Serology for atypicals (Mycoplasma, Chlamydophila)
• Mantoux / IGRA for tuberculosis

Advanced Imaging

• HRCT chest — more sensitive than CXR; detects:
  • Cavitation, abscess, pleural collections
  • "Crazy paving" (alveolar proteinosis)
  • Ground-glass opacities (COP, PCP, drug reaction)
  • Tree-in-bud (endobronchial spread of TB, atypicals)
  • Mediastinal / hilar lymphadenopathy (malignancy, sarcoid)
  • Endobronchial mass / foreign body
  • Underlying structural disease (bronchiectasis, emphysema)

Bronchoscopy (KEY investigation)

• Bronchoalveolar lavage (BAL) — culture (bacteria, fungi, AFB, viruses), cytology, differential cell count (eosinophilia, haemosiderin-laden macrophages)
• Endobronchial biopsy — tumour, granulomas
• Transbronchial biopsy — interstitial lung disease
• Relief of obstruction — foreign body removal
• Protected specimen brush — microbiological sampling

"Bronchoscopy is likely to be useful and should be considered in cases of non-resolving pneumonia, defined as a lack of improvement or worsening of symptoms despite a minimum of 10 days of antibiotic therapy or failure of radiographic abnormalities to resolve after 2 to 3 months." — Fishman's Pulmonary Diseases and Disorders

Additional as indicated

• CT-guided percutaneous needle biopsy — peripheral lesions inaccessible to bronchoscopy
• Video-assisted thoracoscopic surgery (VATS) biopsy — definitive tissue diagnosis
• Pulmonary function tests — if interstitial disease suspected
• Echocardiography — if right heart disease / septic emboli suspected
• Pleural aspiration / thoracocentesis — if significant effusion present (send for LDH, protein, pH, glucose, culture, cytology)

Management

General Principles

1. Reassess antibiotic therapy — review spectrum, dose, route; switch based on culture results
2. Escalate empirically if no organism identified:
   • Broaden to cover atypicals, resistant Gram-negatives, anaerobes, fungi
   • Add anti-TB therapy if risk factors present
3. Treat the underlying cause if non-infectious:
   • Corticosteroids for COP, eosinophilic pneumonia, drug reactions
   • Remove offending drug if drug-induced
   • Surgical/bronchoscopic removal of foreign body
   • Oncological referral for malignancy
4. Drain collections — empyema (tube thoracostomy / VATS decortication), parapneumonic effusion
5. Correct host factors — glycaemic control, treat immunosuppression cause, nutritional support
6. MDT approach — respiratory physician, microbiologist, radiologist, thoracic surgeon

When to Refer / Admit

• Failure to respond after 10 days of appropriate outpatient antibiotics
• Radiographic deterioration or appearance of complications (cavitation, empyema)
• Suspected malignancy
• Severely immunocompromised patient
• Diagnostic uncertainty requiring bronchoscopy or biopsy

Key Points Summary for Exam

Clinical Features of Non-Resolving Pneumonia

1. Features of the Underlying Pneumonia (Initial Presentation)

Symptoms

"Patients with pneumonia frequently will present with cough (79–91%), fatigue (90%), fever (71–75%), dyspnoea (67–75%), sputum production (60–65%), and pleuritic chest pain (39–49%)." — Tintinalli's Emergency Medicine

Signs on Examination

"Clinical signs include tachypnoea, tachycardia, dullness to percussion in areas of consolidation, crackles on auscultation, bronchial breathing, pleural rub, and cyanosis in cases with significant hypoxaemia." — Harrison's Principles of Internal Medicine

2. Typical vs Atypical Presentation

Typical Pneumonia (e.g., S. pneumoniae, H. influenzae)

• Abrupt onset with rigors
• High fever, productive cough with purulent/rusty sputum
• Pleuritic chest pain
• Physical signs of lobar consolidation
• Neutrophilia on CBC
• CXR: lobar/segmental consolidation with air bronchograms

Atypical Pneumonia (e.g., Mycoplasma, Legionella, Chlamydophila, viruses)

• Gradual onset
• Dry, non-productive cough
• Systemic features dominate: headache, myalgia, diarrhoea, confusion
• Relatively normal WBC
• CXR: interstitial / patchy bilateral infiltrates
• Extrapulmonary features:
  • Mycoplasma: myringitis, haemolytic anaemia, rash, encephalitis
  • Legionella: diarrhoea, hyponatraemia, hepatic dysfunction, confusion
  • Viral: generalised alveolar opacities, rapid ARDS progression

3. Features Specific to Non-Resolving Pneumonia

Persistent / Worsening Symptoms Despite Treatment

• Continued fever beyond 5–7 days of appropriate antibiotics
• Persistent or worsening dyspnoea and cough
• Ongoing purulent sputum despite antibiotic coverage
• Weight loss — suggests underlying malignancy or TB
• Night sweats — TB, lymphoma, fungal infection
• Haemoptysis — cavitating organisms (TB, Staph. aureus, Klebsiella) or carcinoma

Persistent Signs on Examination

• Continued dullness and bronchial breathing in the same lobe after >10 days
• Development of stony dullness and absent breath sounds → empyema or enlarging effusion
• New or worsening pleural rub
• Appearance of clubbing — suggests underlying carcinoma or bronchiectasis
• Lymphadenopathy — malignancy, lymphoma, sarcoidosis, TB
• Cachexia / weight loss — chronic infection or underlying malignancy
• Stridor — endobronchial obstruction (tumour, foreign body)
• Skin lesions, joint involvement → systemic vasculitis, sarcoidosis, fungi

Radiographic Non-Resolution

• Failure of opacity to clear on CXR after 4–8 weeks (most should resolve within 4 weeks in young adults; up to 12 weeks in elderly/COPD)
• Worsening opacity / new areas of consolidation
• Cavitation — lung abscess, necrotising pneumonia, TB, fungi
• Increasing pleural effusion → empyema
• Ipsilateral volume loss → obstructing endobronchial lesion (carcinoma)
• Mediastinal/hilar shift or lymphadenopathy → malignancy

4. Features by Underlying Cause

5. Features in Special Populations

Elderly

• Fever absent in 30–40%
• Presents with confusion, falls, functional decline, incontinence
• Tachypnoea may be the only early sign
• Diagnosis frequently delayed → increased mortality

Immunocompromised (HIV, transplant, chemotherapy)

• Atypical, insidious onset
• May lack fever and signs despite severe infection
• CXR may be normal early in PCP
• High risk: Pneumocystis, CMV, Aspergillus, atypical mycobacteria

Alcoholics / Aspiration risk

• Lower lobe / right middle lobe posterior segment involvement
• Anaerobic organisms; foul-smelling sputum
• Risk of lung abscess

Summary Table